CORBUS PHARMACEUTICALS HLDGS's ticker is CRBP and the CUSIP is 21833P103. A total of 113 filers reported holding CORBUS PHARMACEUTICALS HLDGS in Q4 2020. The put-call ratio across all filers is 0.88 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $1 | -99.9% | 10,600 | 0.0% | 0.00% | – |
| Q3 2022 | $1,000 | -50.0% | 10,600 | 0.0% | 0.00% | – |
| Q2 2022 | $2,000 | -60.0% | 10,600 | 0.0% | 0.00% | – |
| Q1 2022 | $5,000 | -16.7% | 10,600 | 0.0% | 0.00% | – |
| Q4 2021 | $6,000 | -40.0% | 10,600 | 0.0% | 0.00% | – |
| Q3 2021 | $10,000 | -47.4% | 10,600 | 0.0% | 0.00% | -100.0% |
| Q2 2021 | $19,000 | -5.0% | 10,600 | -1.9% | 0.00% | 0.0% |
| Q1 2021 | $20,000 | +53.8% | 10,800 | -7.7% | 0.00% | 0.0% |
| Q4 2020 | $13,000 | -69.0% | 11,700 | -66.3% | 0.00% | -66.7% |
| Q3 2020 | $42,000 | +366.7% | 34,700 | +71.2% | 0.00% | +200.0% |
| Q4 2018 | $9,000 | -75.0% | 20,265 | -29.7% | 0.00% | -50.0% |
| Q3 2018 | $36,000 | +9.1% | 28,817 | +289.4% | 0.00% | -33.3% |
| Q1 2018 | $33,000 | -62.5% | 7,400 | -48.4% | 0.00% | -25.0% |
| Q4 2017 | $88,000 | +417.6% | 14,354 | -77.3% | 0.00% | – |
| Q3 2017 | $17,000 | -82.3% | 63,297 | -45.5% | 0.00% | -100.0% |
| Q2 2017 | $96,000 | -48.4% | 116,056 | -49.2% | 0.00% | -50.0% |
| Q1 2017 | $186,000 | +24.0% | 228,456 | +138.3% | 0.01% | +33.3% |
| Q4 2016 | $150,000 | +2400.0% | 95,856 | +4464.6% | 0.01% | – |
| Q3 2016 | $6,000 | – | 2,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 3,738,925 | $23,555,000 | 31.22% |
| Perceptive Advisors | 1,232,500 | $7,764,000 | 0.39% |
| IFP Advisors, Inc | 1,001,025 | $6,306,000 | 0.27% |
| WOODSTOCK CORP | 55,489 | $350,000 | 0.07% |
| Virtus ETF Advisers LLC | 50,795 | $320,000 | 0.05% |
| Dynamic Technology Lab Private Ltd | 31,431 | $198,000 | 0.04% |
| Evanson Asset Management, LLC | 20,660 | $130,000 | 0.03% |
| Artal Group S.A. | 250,000 | $1,575,000 | 0.03% |
| GSA CAPITAL PARTNERS LLP | 58,800 | $370,000 | 0.02% |
| Raymond James Financial Services Advisors, Inc. | 426,280 | $2,686,000 | 0.02% |